Healthcare
Live Price
Offline$9.16
-1.51% today
1Y Change
+70.50%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Vir Biotechnology, Inc. (VIR) is a Healthcare stock with a market cap of $1.61B and listed on NASDAQ. The stock last traded around $9.16 and up 70.5% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -7.6%, EPS growth of +17.5%, a dividend yield of 0.0%. What stands out right now is revenue -7.6%, EPS +17.5%, free cash flow +12.6% with operating margin -682.7% and ROIC -50.9%. Valuation already assumes a fairly strong business story at price/sales 23.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VIR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VIR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VIR Max Drawdown
-27.82%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VIR and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.